Latest / Decera Clinical Education Oncology Podcast
Experts Discuss Novel Approaches to First-line Therapy for HER2-Positive Metastatic Breast Cancer
In this podcast episode, Erika Hamilton, MD, FASCO, and Ian Krop, MD, PhD, discuss recent developments in the field of first-line therapy and maintenance treatment for patients with HER2-positive metastatic breast cancer, including the following:
Trastuzumab deruxtecan plus pertuzumab as first-line therapy based on data from DESTINY-Breast09
Adding palbociclib to HP and ET as maintenance therapy for HR-positive/HER2-positive MBC, based on data from PATINA
Adding tucatinib to HP as maintenance therapy for HER2-positive MBC, based on data from HER2CLIMB-05
Presenters:
Erika Hamilton, MD, FASCO…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.